BioPharma Services announces successful completion of Austrian Regulatory Agency (AGES) Audit
BioPharma Services Inc. is happy to report the successful completion of another regulatory industry audit. During the week of September 12, 2022, BioPharma was host to a multi-agency inspection. Leading the inspection were inspectors from the Austrian Agency for...
New BioPharma Contracts Signed During Q3 2022 Valued at $12.8 Million
Revenue recognition commencing in September to October timeframe. Average length of each program is approximately 12 months. TORONTO, ON, March 29, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a healthcare technology company focused on...
BioPharma Services Achieves Another Successful FDA Inspection Result
TORONTO, ON - June 16, 2022 - Think Research Corporation (TSXV:THNK) (OTCQB: THKKF) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, is pleased to announce its subsidiary, BioPharma Services Inc.,...
BioPharma Services Receives 2022 Biotechnology Award from GHP
TORONTO, ON, April 29, 2022 – Slated for being a Leading Provider of Pharma Product of Clinical Trial Services in 2022, BioPharma Services Inc. is happy to announce its acceptance of the Biotechnology Award for this year. Presented by Global Health & Pharma...
BioPharma Services Receives Pharma Tech Outlook Top 10 CRO’s of 2022 Award
TORONTO, ON, April 28, 2022 – BioPharma Services Inc. is delighted to announce the acceptance of the Pharma Tech Outlook Top CRO's of 2022 award. Pharma Tech Outlook is a print and digital magazine that provides a knowledge network for scaling pharma technology...
BioPharma’s parent company Think Research progresses the digitization of Phase 1 clinical trials
TORONTO, ON, March 29, 2022 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced the launch of its clinical trial Electronic Data Capture (“EDC”)...
Think Research Corporation Closes Acquisition of Bio Pharma Services Inc.
Toronto, ON, September 13, 2021 – Think Research Corporation (TSXV:THNK) (“Think” or the “Company”), a company focused on transforming healthcare through digital health software solutions, today announced that it has closed its previously announced acquisition of all...
BioPharma Services enhances systems with new Quality Management solution
BioPharma Services is proud to announce that the Dot Compliance suite, a cloud based highly secure Quality Management System (eQMS) solution for life science companies powered by the Salesforce platform, has now been integrated. Salesforce is the leading platform for...
From Surviving To Thriving, BioPharma Addresses Complex Challenges Through Clinical Trials
Surgeons work an average of 60 hours per week in high-pressure environments, after years of medical school and extensive training. This doesn’t consider continuing education, credentialing, on-call responsibilities and much more. For Drs. Fathi Abuzgaya and Esmat...
BioPharma Services Inc. Signs Agreement to be Acquired by Think Research Corporation
On July 15, 2021, BioPharma Services announced that it had entered into a definitive agreement to be acquired by Think Research Corporation. Transaction Highlights: Highly strategic deal will expand THINK’S ability to move data through health systems to deliver better...
Schedule a Discovery
Call Today
Complete the form to schedule a Discovery Call with one of our medical experts to learn how BioPharma Services can be your trusted clinical trial partner.